ZANINOTTO, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 11.112
AS - Asia 3.567
EU - Europa 2.241
AF - Africa 1.000
SA - Sud America 798
OC - Oceania 116
Continente sconosciuto - Info sul continente non disponibili 57
Totale 18.891
Nazione #
US - Stati Uniti d'America 10.634
SG - Singapore 1.245
CN - Cina 650
HK - Hong Kong 483
BR - Brasile 463
FI - Finlandia 249
VN - Vietnam 229
DE - Germania 212
SE - Svezia 196
UA - Ucraina 177
IT - Italia 140
FR - Francia 123
RU - Federazione Russa 98
GB - Regno Unito 95
PL - Polonia 88
NL - Olanda 63
AT - Austria 61
AR - Argentina 56
IQ - Iraq 53
IN - India 50
IE - Irlanda 49
UZ - Uzbekistan 47
TR - Turchia 44
ZA - Sudafrica 44
BJ - Benin 43
CL - Cile 43
ES - Italia 41
AL - Albania 40
MX - Messico 40
SN - Senegal 40
AO - Angola 39
VE - Venezuela 39
ID - Indonesia 38
JP - Giappone 36
GM - Gambi 35
YE - Yemen 35
AE - Emirati Arabi Uniti 34
CZ - Repubblica Ceca 34
KR - Corea 34
DO - Repubblica Dominicana 33
PA - Panama 33
SA - Arabia Saudita 33
UY - Uruguay 33
BZ - Belize 32
GR - Grecia 32
PY - Paraguay 32
BY - Bielorussia 31
CI - Costa d'Avorio 31
EC - Ecuador 31
CU - Cuba 30
ET - Etiopia 30
KE - Kenya 30
RS - Serbia 30
SO - Somalia 30
TJ - Tagikistan 30
BG - Bulgaria 29
BO - Bolivia 29
HN - Honduras 29
ML - Mali 29
PT - Portogallo 29
SK - Slovacchia (Repubblica Slovacca) 29
UG - Uganda 29
XK - ???statistics.table.value.countryCode.XK??? 29
AZ - Azerbaigian 28
HR - Croazia 28
HU - Ungheria 28
MZ - Mozambico 28
NZ - Nuova Zelanda 28
AU - Australia 27
IL - Israele 27
LA - Repubblica Popolare Democratica del Laos 27
MN - Mongolia 27
MW - Malawi 27
PK - Pakistan 27
CW - ???statistics.table.value.countryCode.CW??? 26
DK - Danimarca 26
JM - Giamaica 26
KH - Cambogia 26
MK - Macedonia 26
MY - Malesia 26
PE - Perù 26
RW - Ruanda 26
TN - Tunisia 26
YT - Mayotte 26
ZW - Zimbabwe 26
CH - Svizzera 25
GF - Guiana Francese 25
HT - Haiti 25
LU - Lussemburgo 25
LV - Lettonia 25
MD - Moldavia 25
ME - Montenegro 25
NP - Nepal 25
SI - Slovenia 25
CV - Capo Verde 24
EG - Egitto 24
GE - Georgia 24
MA - Marocco 24
MG - Madagascar 24
PH - Filippine 24
Totale 17.810
Città #
Fairfield 1.700
Woodbridge 996
Ashburn 895
Houston 831
Jacksonville 725
Singapore 656
Chandler 654
Wilmington 625
Seattle 624
Cambridge 568
Ann Arbor 528
Hong Kong 455
Princeton 277
Boardman 201
Santa Clara 198
San Diego 180
Beijing 172
Roxbury 101
Los Angeles 95
Nanjing 92
Helsinki 87
Des Moines 74
Ho Chi Minh City 66
Dong Ket 55
Chicago 54
Bytom 52
Medford 49
Dublin 44
Tashkent 42
Hanoi 41
Padova 41
Shenyang 41
New York 40
Vienna 40
Dakar 39
Cotonou 38
Buffalo 36
Luanda 36
Guangzhou 34
Munich 32
São Paulo 31
Abidjan 29
Bamako 28
Dushanbe 28
Kampala 28
Panama City 28
Havana 27
Ulan Bator 27
Kigali 26
Nanchang 26
Baku 25
Hebei 25
Montevideo 25
Nairobi 24
Amman 23
Harare 23
Lusaka 23
Nassau 23
Vientiane 23
Willemstad 23
Maputo 22
Minsk 22
Norwalk 22
Podgorica 22
Castries 21
Council Bluffs 21
Phnom Penh 21
Tirana 21
Cayenne 20
Libreville 20
Lilongwe 20
Nouakchott 20
Riga 20
Sofia 20
Tbilisi 20
Warsaw 20
Addis Ababa 19
Antananarivo 19
Bishkek 19
Conakry 19
Dili 19
Noumea 19
Nuremberg 19
Praia 19
Andorra la Vella 18
Chisinau 18
Jiaxing 18
Johannesburg 18
London 18
Managua 18
Pristina 18
Baghdad 17
Banjul 17
Belize City 17
Bridgetown 17
Changsha 17
Dar es Salaam 17
Falls Church 17
Istanbul 17
Salt Lake City 17
Totale 12.792
Nome #
Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled cases 233
Role of proton pump inhibitor on esophageal carcinogenesis and pancreatic acinar cell metaplasia development: an experimental in vivo study. 215
ALTERED ESOPHAGEAL PAIN THRESHOLD IN IRRITABLE-BOWEL-SYNDROME 202
CDX2 hox gene product in a rat model of esophageal cancer 197
The preoperative manometric pattern predicts the outcome of surgical treatment for esophageal achalasia. 195
Laparoscopic Heller myotomy can be used as primary therapy for esophageal achalasia regardless of age 192
Aurora kinase A in Barrett's carcinogenesis. 189
Oxidative DNA Damage in Barrett Mucosa: Correlation with Telomeric Dysfunction and p53 Mutation. 186
Herpes simplex Virus type 1 Infection of the Rat Enteric Nervous System Evokes Small Bowel Neuromuscular Abnormalities. 185
The Veneto Region's Barrett's Oesophagus Registry: Aims, methods, preliminary results. 184
The role of botulinum toxin injection and upper esophageal sphincter myotomy in treating oropharyngeal dysphagia 183
Diffuse esophageal spasm: the surgical approach 182
Human epithelial growth factor receptor 2 (HER2) status in primary and metastatic esophagogastric junction adenocarcinomas. 178
MicroRNA expression profiling in human Barrett's carcinogenesis. 178
Esophageal motor function in patients with myotonic dystrophy 177
Barrett's epithelium after antireflux surgery 177
Oesophageal resection for high-grade dysplasia in Barrett's oesophagus 176
MicroRNA Expression Profiling in the Histological Subtypes of Barrett's Metaplasia. 175
Programmed cell death 4 protein in esophageal cancer 173
Radiological evidence of subclinical dysphagia in motor neuron disease 173
Toll-like Receptor 2 Regulates Intestinal Inflammation by Controlling Integrity of the Enteric Nervous System 173
Programmed cell death 4 nuclear loss and miR-21 or activated Akt overexpression in esophageal squamous cell carcinogenesis. 171
Squamous cell carcinoma antigen (SCCA) is up-regulated during Barrett's carcinogenesis and predicts esophageal adenocarcinoma resistance to neoadjuvant chemotherapy 171
SEQUENTIAL INTRALUMINAL ENDOSCOPIC AND LAPAROSCOPIC TREATMENT FOR BILE DUCT STONES ASSOCIATED WITH GALLSTONES. 170
Therapeutic Strategies for Epiphrenic Diverticula: Systematic Review 169
The HER2-miR125a5p/miR125b loop in gastric and esophageal carcinogenesis. 169
Anterior gradient 2 profiling in Barrett columnar epithelia and adenocarcinoma. 166
Pneumatic Dilation versus Laparoscopic Heller's Myotomy for Idiopathic Achalasia 165
Pericentriolar material analyses in normal esophageal mucosa, Barrett's metaplasia and adenocarcinoma 163
Long-term outcome and risk of oesophageal cancer after surgery for achalasia. 162
Shorter myotomy on the gastric site (≤2.5 cm) provides adequate relief of dysphagia in achalasia patients 162
Altered Intestinal Motility Following Enteric Nervous System Infection by Herpes Simplex Virus Type 1 is Related to Gut Neuroanatomical and Neurochemical Abnormalities 160
Erosion of an esophageal endoprosthesis into the trachea 157
Circulating microRNA expression profiling revealed miR-92a-3p as a novel biomarker of Barrett's carcinogenesis 155
T cells in the myenteric plexus of achalasia patients show a skewed TCR repertoire and react to HSV-1 antigens 154
Esophageal achalasia: Is the herpes simplex virus really innocent? 151
Zenker's Diverticula: Feasibility of a Tailored Approach Based on Diverticulum Size 151
Intestinal or gastric? The unsolved dilemma of Barrett's metaplasia 151
Barrett’s Esophagus and Adenocarcinoma Risk The Experience of the North-Eastern Italian Registry (EBRA) 150
Achalasia: Pneumatic Dilation or Laparoscopic Heller Myotomy? 150
Laparoscopic live donor nephrectomy: Single center experience 149
Altered intestinal motility following enteric nervous system infection by Herpes Simplex Virus 1 148
Long-term outcome of operated and unoperated epiphrenic diverticula 148
MicroRNA Dysregulation in Esophageal Neoplasia: The Biological Rationale for Novel Therapeutic Options. 148
The 2018 ISDE Achalasia guidelines 146
Successful treatment of long-standing post-stroke dysphagia with botulinum toxin and rehabilitation 144
Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis. 144
Esophageal GIST: Case report of surgical enucleation and update on current a diagnostic and therapeutic options 143
Barrett's epithelium after antireflux surgery 142
Helicobacter pylori, inflammation, oxidative damage and gastric cancer: a morphological, biological and molecular pathway. 141
Laparoscopic Repair of Epiphrenic Diverticulum 140
ONE YEAR FOLLOW-UP AFTER LAPAROSCOPIC HELLER-DOR OPERATION FOR ESOPHAGEAL ACHALASIA 139
Long-term results of the European Achalasia trial: A multicentre randomised Controlled trial comparing pneumatic dilation versus laparoscopic Heller myotomy 137
Barrett's registries in Europe: report of an international workshop 136
Gastric precancerous lesion follow up based on pathological evidence 135
Minimally invasive enucleation of esophageal leiomyoma 135
Achalasia and esophago-gastric junction outflow obstruction: focus on the subtypes 135
Endoscopic and surgical management of achalasia 134
Surgical management of refractory gastro-oesophageal reflux 134
Botulinum toxin injection versus laparoscopic myotomy for the treatment of esophageal achalasia: economic analysis of a randomized trial 134
Etiology, diagnosis and treatment of failures after laparoscopic Heller Myotomy for achalasia 134
Laparoscopic Re-Do Myotomy for Recurrent Achalasia After Heller-Dor Procedure 132
Objective follow-up after laparoscopic repair of large type III hiatal hernia. Assessment of safety and durability 130
Long-term follow-up of Barrett's epithelium: medical versus antireflux surgical therapy. 130
Surgical complications do not affect longterm survival after esophagectomy for carcinoma of the thoracic esophagus and cardia. 130
Survivin in esophageal cancer: An accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma 129
The Kagoshima consensus on esophageal achalasia 129
DNA copy number alterations correlate with survival in esophageal adenocarcinoma patients. 129
Chylothorax complicating esophagectomy for cancer: A plea for early thoracic duct ligation 128
Surgical options and outcomes in Barrett's esophagus 127
Endoscopic treatment of gastroesophageal reflux disease 126
The short esophagus: Intraoperative assessment of esophageal length 126
The never-ending story of dilatation versus surgery for oesophageal achalasia 125
Manometric characteristics of the distal oesophageal sphincter and patterns of gastro-oesophageal reflux in healthy volunteers and patients 125
Barrett's Esophagus: Still Much to Learn, But "Yes, We Can!" 124
Oesophageal diverticula 124
The Myotomy Length on the Gastric Side Doesn't Influence the Final Outcome of Laparoscopic Heller Dor for Esophageal Achalasia 124
Early HER2 dysregulation in gastric and oesophageal carcinogenesis. 124
Economic evaluation of the randomized European Achalasia trial comparing pneumodilation with Laparoscopic Heller myotomy 124
Functional and morphological study of the cricopharyngeal muscle in patients with Zenker's diverticulum 123
Pseudoachalasia: not only esophago-gastric cancer 122
Randomized controlled trial of botulinum toxin versus laparoscopic heller myotomy for esophageal achalasia 122
Long-term outcome of laparoscopic Heller-Dor surgery for esophageal achalasia: Possible detrimental role of previous endoscopic treatment 122
Expression of survivin, p53, and caspase 3 in Barrett's esophagus carcinogenesis 121
Outcomes of treatment for achalasia depend on manometric subtype 120
Esophageal Achalasia in the Veneto Region: Epidemiology and Treatment Epidemiology and Treatment of Achalasia 118
Minimally invasive surgery for esophageal achalasia 118
Re: CDX2 homeotic gene expression in gastric noninvasive neoplasia 117
One-year follow-up after laparoscopic Heller-Dor operation for esophageal achalasia 116
Mediastinal carcinosis involving the esophagus in breast cancer: the"breast-esophagus" syndrome: report on 25 cases and guidelines for diagnosis andtreatment. 115
Re: Risk of Malignant Progression in Barrett's Esophagus Patients: Results from a Large Population-Based Study. 115
LAPAROSCOPIC VERSUS CONVENTIONAL SURGERY FOR SUSPECTED APPENDICITIS IN WOMEN 115
ESOPHAGEAL ACHALASIA - LAPAROSCOPIC VERSUS CONVENTIONAL OPEN HELLER-DOR OPERATION 114
Selected Commentary to "Pneumatic dilation versus laparoscopic Heller's myotomy for idiopathic achalasia" 113
MAGE, BAGE, and GAGE overexpression in patients with esophageal squamous cell carcinoma and adenocarcinoma of gastric cardia 112
Only Pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma Final report of a randomized, controlled trial of preoperative chemotherapy versus surgery Alone 111
Long-term results (6-10 years) of laparoscopic fundoplication 111
The Fate of Barrett's Epithelium Under Acid Suppression Obtained by Medical or Surgical Therapy 110
ESOPHAGITIS AND PH OF THE REFLUXATE - EXPERIMENTAL AND CLINICAL-STUDY 109
Management of minimally symptomatic pulsion diverticula of the esophagus 109
Totale 14.635
Categoria #
all - tutte 59.688
article - articoli 57.599
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 721
Totale 118.008


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.184 0 0 0 0 33 115 85 196 275 176 169 135
2021/20222.022 65 178 260 140 113 106 81 248 172 37 238 384
2022/20231.310 310 134 28 147 215 187 0 82 163 0 37 7
2023/2024621 46 85 76 43 34 71 25 33 31 28 81 68
2024/20252.531 7 150 117 84 367 85 83 186 256 98 414 684
2025/20265.401 354 963 1.637 1.947 500 0 0 0 0 0 0 0
Totale 18.960